Literature DB >> 22014557

Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia.

Jean-Guillaume Dillinger, Georgios Sideris, Patrick Henry, Claire Bal dit Sollier, Emily Ronez, Ludovic Drouet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22014557     DOI： 10.1016/j.thromres.2011.09.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  14 in total

Review 1.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

Review 2.  Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas.

Authors:  Shubhabrata Das; Anasua Deb; Tanmoy Pal
Journal:  Med Princ Pract       Date:  2021-04-13       Impact factor: 1.927

3.  Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

Authors:  Alberto Tosetto; Bianca Rocca; Giovanna Petrucci; Silvia Betti; Denise Soldati; Elena Rossi; Andrea Timillero; Viviana Cavalca; Benedetta Porro; Alessandra Iurlo; Daniele Cattaneo; Cristina Bucelli; Alfredo Dragani; Mauro Di Ianni; Paola Ranalli; Francesca Palandri; Nicola Vianelli; Eloise Beggiato; Giuseppe Lanzarone; Marco Ruggeri; Giuseppe Carli; Elena Maria Elli; Stefania Priolo; Maria Luigia Randi; Irene Bertozzi; Giuseppe Gaetano Loscocco; Alessandra Ricco; Giorgina Specchia; Alessandro Maria Vannucchi; Francesco Rodeghiero; Valerio De Stefano; Carlo Patrono
Journal:  Clin Pharmacol Ther       Date:  2021-11-20       Impact factor: 6.903

Review 4.  Essential thrombocythemia treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

5.  Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study.

Authors:  Florian Prüller; Oliver Leopold Milke; Lukasz Bis; Friedrich Fruhwald; Daniel Scherr; Philipp Eller; Sascha Pätzold; Siegfried Altmanninger-Sock; Peter Rainer; Jolanta Siller-Matula; Dirk von Lewinski
Journal:  Ann Intensive Care       Date:  2018-02-21       Impact factor: 6.925

Review 6.  Polycythemia vera treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

7.  The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

Authors:  Valerio De Stefano; Bianca Rocca; Alberto Tosetto; Denise Soldati; Giovanna Petrucci; Eloise Beggiato; Irene Bertozzi; Silvia Betti; Giuseppe Carli; Monica Carpenedo; Daniele Cattaneo; Viviana Cavalca; Alfredo Dragani; Elena Elli; Guido Finazzi; Alessandra Iurlo; Giuseppe Lanzarone; Laura Lissandrini; Francesca Palandri; Chiara Paoli; Alessandro Rambaldi; Paola Ranalli; Maria Luigia Randi; Alessandra Ricco; Elena Rossi; Marco Ruggeri; Giorgina Specchia; Andrea Timillero; Linda Turnu; Nicola Vianelli; Alessandro M Vannucchi; Francesco Rodeghiero; Carlo Patrono
Journal:  Blood Cancer J       Date:  2018-06-01       Impact factor: 11.037

8.  Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.

Authors:  T Barbui; A M Vannucchi; V Buxhofer-Ausch; V De Stefano; S Betti; A Rambaldi; E Rumi; M Ruggeri; F Rodeghiero; M L Randi; I Bertozzi; H Gisslinger; G Finazzi; A Carobbio; J Thiele; F Passamonti; C Falcone; A Tefferi
Journal:  Blood Cancer J       Date:  2015-11-27       Impact factor: 11.037

9.  An agenda for future research projects in polycythemia vera and essential thrombocythemia.

Authors:  Tiziano Barbui; Alessandro Maria Vannucchi; Paola Guglielmelli; Valerio De Stefano; Alessandro Rambaldi
Journal:  Haematologica       Date:  2020-05-28       Impact factor: 9.941

10.  What cardiologists should know about essential thrombocythemia and acute myocardial infarction: report of two cases and advanced heart failure therapies considerations.

Authors:  Marie-Camille Soucy-Giguère; Pierre Yves Turgeon; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.